Representative before the EPO

Company dna cabinet lavoix
no operation time available
1069.27
2 offices
active in Legal Services

Béatrice Holtz has worked on the following 10 EPO patent applications which have been published in the last five years:

EP12721529

USE OF ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE ANTIBODY FOR THE TREATMENT OF B-CELL MALIGNANCIES SYMPTOMS

IPC classification:
A61K 47/48, C07K 16/28
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
EXAMINATION IN PROGRESS
EP12722150

METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF HAVING OR DEVELOPING A CHRONIC KIDNEY DISEASE

IPC classification:
C12Q 1/68
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Assistance Publique Hôpitaux de Paris
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Denise Marie Hirsch, Inserm Transfert
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12740557

METHODS FOR DETERMINING TREATMENT RESPONSE IN PATIENTS INFECTED WITH HCV GENOTYPE 4

IPC classification:
C12Q 1/68, C12Q 1/70
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
Université Paris Diderot - Paris 7
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Denise Marie Hirsch, Inserm Transfert
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12740174

COMBINATION THERAPY FOR THE TREATMENT OF CD19+ B-CELL MALIGNANCIES SYMPTOMS COMPRISING AN ANTI-CD19 MAYTANSINOID IMMUNOCONJUGATE AND RITUXIMAB

IPC classification:
A61K 39/395, A61K 47/48, A61P 35/00, C07K 16/28
Applicant:
Sanofi, S.A.
Agent:
Carin Marie Lisa Ribard, Sanofi, S.A.
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Carin Marie Lisa Ribard, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12769684

COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME

IPC classification:
A61K 31/42, A61K 31/519, A61K 31/655, A61K 39/395, A61K 45/06, C07K 16/28
Applicant:
Sanofi, S.A.
Applicant:
Regeneron Pharmaceuticals Inc
Agent:
Philippe Bouvet, Sanofi, S.A.
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Philippe Bouvet, Sanofi
Status:
GRANT OF PATENT INTENDED
EP12780496

METHOD FOR PREDICTING THE PRESENCE OF REPRODUCTIVE CELLS IN TESTIS

IPC classification:
G01N 33/68
Applicant:
Université de Rennes 1
Applicant:
Institut National de la Santé et de la Recherche Médicale (INSERM)
Applicant:
University of the French West Indies and Guiana (Université des Antilles et da la Guyane)
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Denise Marie Hirsch, Inserm Transfert
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11719346

ROBO1-FC FUSION PROTEIN AND USE THEREOF FOR TREATING TUMOURS

IPC classification:
A61K 38/00, C07K 14/475
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Elsa Martin-Touaux, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13732225

LOW-DENSITY HOT- OR COLD-ROLLED STEEL, METHOD FOR IMPLEMENTING SAME AND USE THEREOF

IPC classification:
C21D 8/02, C21D 9/46, C22C 38/02, C22C 38/04, C22C 38/06
Applicant:
Arcelormittal Investigación y Desarrollo SL
Applicant:
ArcelorMittal SA
Agent:
Béatrice Holtz, Cabinet Lavoix
Agent:
Sophie Marie Plaisant, ArcelorMittal France SA
Agent:
Sophie Marie Plaisant, ArcelorMittal Research & Development
Status:
PATENT GRANTED
EP11790890

VERTICAL AXIS WIND TURBINE HAVING ONE OR MORE MODULAR BLADES

IPC classification:
F03D 3/06
Agent:
Paul William Loustalan, Reddie & Grose LLP
Agent:
Béatrice Holtz, Cabinet Lavoix
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature